LAVA Therapeutics NV

Ownership Transactions Reported by 10 Insiders

Symbol
LVTX on Nasdaq
Location
Yalelaan 62, Utrecht, Netherlands

There are no Buy or Sell transactions made by insiders since 1/9/2024

LAVA Therapeutics NV executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Stephen A. Hurly Chief Executive Officer, Director Jan 1, 2025
Fred M. Powell Chief Financial Officer Jan 1, 2025
Charles Q. Morris Chief Medical Officer Jan 1, 2025
Jay T. Backstrom Director Jan 1, 2025
Kapil Dhingra Director Jan 1, 2025
Peter Kiener Director Jan 1, 2025
James Noble Director Jan 1, 2025
Christy J. Oliger Director Jan 1, 2025
Karen J. Wilson Director Jan 1, 2025
Mary E. Wadlinger Director Jan 1, 2025

There are no transactions filed by insiders of LAVA Therapeutics NV